News &amp; Updates

An artificial intelligence (AI)-based model, dubbed AI-Thyroid, for the diagnosis of thyroid cancer demonstrates its utility in improving diagnostic performance and interobserver agreement, which could be helpful in less-experienced physicians, reports a study.

AI model improves thyroid cancer diagnosis

Prophylactic oropharyngeal surfactant does little to reduce intubation risk in preemies

Administration of surfactant into the oropharynx of neonates delivered before 29 weeks of gestation falls short of reducing the rate of intubation in the first 120 hours of life, according to the results of POPART*.

Prophylactic oropharyngeal surfactant does little to reduce intubation risk in preemies

Sibeprenlimab shows promise in IgA nephropathy

In the treatment of patients with IgA nephropathy, the use of sibeprenlimab, a humanized IgG2 monoclonal antibody that binds to and neutralizes a proliferation-inducing ligand (APRIL), appears to lead to a significant reduction in proteinuria, according to a phase II trial.

Sibeprenlimab shows promise in IgA nephropathy

Intensive lifestyle intervention reduces long-term variability in blood sugar, lipids

11 Feb 2024 by

For people with overweight or obesity and type 2 diabetes, intensive lifestyle intervention appears to minimize the spikes and drops in cardiovascular risk factors such as blood glucose and lipids.

Intensive lifestyle intervention reduces long-term variability in blood sugar, lipids

11 Feb 2024

Cardiogenic shock ups risk of death in hospitalized children with ADHF

Nearly one in four children hospitalized for acute decompensated heart failure (ADHF) had cardiogenic shock (CS), which may lead to death, reports a study.

Cardiogenic shock ups risk of death in hospitalized children with ADHF

11 Feb 2024

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

The glucagon/GLP-1 receptor dual agonist survodutide appears to be safe and induce weight loss in individuals with obesity, according to data from a phase II dose-finding trial.

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

Novel anti-influenza A virus inhibitor works in patients with uncomplicated flu infection

Treatment with the anti-influenza A virus inhibitor onradivir is safe and leads to symptom improvement and viral load reduction in adults with uncomplicated influenza infection, according to data from a phase II trial.

Novel anti-influenza A virus inhibitor works in patients with uncomplicated flu infection

Reduced social isolation, loneliness helps people with obesity live longer

10 Feb 2024 by

Addressing social isolation and loneliness in people with obesity can counter their increased risk of death, according to a study.

Reduced social isolation, loneliness helps people with obesity live longer

Cardiovascular risks high after PCI, CABG but decrease in time